Brief: Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita Maintained Weight Loss After GLP-1 Discontinuation
26/09/2025 12:09
Sept 26 (Reuters) - Fractyl Health Inc GUTS.O: FRACTYL HEALTH ANNOUNCES GROUNDBREAKING DATA FROM REMAIN-1 MIDPOINT COHORT SHOWING REVITA® MAINTAINED WEIGHT LOSS AFTER GLP-1 DISCONTINUATION FRACTYL HEALTH INC - STUDY MET 3-MONTH EFFICACY ENDPOINT WITH STRONG STATISTICAL SIGNIFICANCE FRACTYL HEALTH INC - REVITA PROCEDURE DEMONSTRATED EXCELLENT SAFETY AND TOLERABILITY TO DATE Source text: ID:nGNXbKgsPm Further company coverage: GUTS.O ((Reuters.Briefs@thomsonreuters.com;))